| Original language | Italian |
|---|---|
| Pages (from-to) | 1870-1880 |
| Number of pages | 11 |
| Journal | International Journal of Cancer |
| Volume | 140 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2017 |
Cite this
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors. / Peverelli, E.; Giardino, E.; Treppiedi, D.; Meregalli, M.; Belicchi, M.; Vaira, V.; Corbetta, S.; Verdelli, C.; Verrua, E.; Serban, A.L.; Locatelli, M.; Carrabba, G.; Gaudenzi, G.; Malchiodi, E.; Cassinelli, L.; Lania, A.G.; Ferrero, S.; Bosari, S.; Vitale, G.; Torrente, Y.; Spada, A.; Mantovani, G.
In: International Journal of Cancer, Vol. 140, No. 8, 2017, p. 1870-1880.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
AU - Peverelli, E.
AU - Giardino, E.
AU - Treppiedi, D.
AU - Meregalli, M.
AU - Belicchi, M.
AU - Vaira, V.
AU - Corbetta, S.
AU - Verdelli, C.
AU - Verrua, E.
AU - Serban, A.L.
AU - Locatelli, M.
AU - Carrabba, G.
AU - Gaudenzi, G.
AU - Malchiodi, E.
AU - Cassinelli, L.
AU - Lania, A.G.
AU - Ferrero, S.
AU - Bosari, S.
AU - Vitale, G.
AU - Torrente, Y.
AU - Spada, A.
AU - Mantovani, G.
N1 - Cited By :1 Export Date: 9 February 2018
PY - 2017
Y1 - 2017
U2 - 10.1002/ijc.30613
DO - 10.1002/ijc.30613
M3 - Articolo
VL - 140
SP - 1870
EP - 1880
JO - International Journal of Cancer
JF - International Journal of Cancer
SN - 0020-7136
IS - 8
ER -